ARTICLE | Clinical News
RT002: Ph II started
November 4, 2016 7:58 PM UTC
Revance began a double-blind, placebo-controlled, U.S. Phase II trial to evaluate a single injection of RT002 in 60 patients....
BCIQ Company Profiles
Revance began a double-blind, placebo-controlled, U.S. Phase II trial to evaluate a single injection of RT002 in 60 patients....
BCIQ Company Profiles